An influential U.S. drug pricing watchdog raised the price estimate of two experimental gene therapies from Vertex Pharmaceuticals /CRISPR Therapeutics and bluebird bio to as much as $2.05 mln, saying the new price can be cost effective to treat sickle cell disease.
J.P. Morgan has become the latest major bank struggling to find Russian stocks linked to some client investments, adding to fears for investors still hoping to recoup some value from stranded assets in the country.
Wie Lenzing Bawag voestalpine DO&CO EVN und Verbund für Gesprächsstoff im ATX sorgten ATX: +0 44% Aktie Symbol SK Perf. Bawag BG 41.52 2.27% voestalpine VOE 31.62 2.13% DO&CO DOC 125 1.63% VER 71.2 -0.70% 20.65 -1.20% Lenzing LNZ 42.35 -5.15% Social
Sergio Ermotti faces the daunting task of integrating two globally systemic banks. The returning UBS boss’s first big decision, though, has a more domestic focus. The Swiss bank is under pressure to offload Credit Suisse’s local business to ease a political backlash in its home market. By avoiding immediate layoffs, and arguing that the division might not be viable on its own, he might be able to get away with keeping it.
Eaton Vance Municipal Income Trust (NYSE:EVN – Free Report) announced a dividend on Monday, July 3rd, NASDAQ reports. Stockholders of record on Thursday, July 13th will be given a dividend of 0.0375 per share by the investment management company on Thursday, July 20th. The ex-dividend date of this dividend is Wednesday, July 12th. Eaton Vance […]